AmeriFlex Group’s Halozyme HALO Stock Holding History

AmeriFlex Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$31.9K	–	1152
2025 Q1	$31.9K	Hold	500	–	–	0.01%	589
2024 Q4	$28.3K	Buy	+500	New	+$25.6K	0.01%	558

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AmeriFlex Group's HALO Position: Q2 2025 in Review

AmeriFlex Group sold out of Halozyme (HALO) in Q2 2025, closing a stake of 500 shares — an estimated $31.9K sold.

AmeriFlex Group first reported a position in HALO in Q4 2024 and held it in 2 quarters. The position peaked at $31.9K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

AmeriFlex Group reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
AmeriFlex Group sold 500 Halozyme shares in Q2 2025, an estimated $31.9K.
AmeriFlex Group first reported a position in Halozyme in Q4 2024 and held it in 2 quarters.
AmeriFlex Group's Halozyme position peaked at $31.9K in Q1 2025.
551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on AmeriFlex Group's 13F filing for Q2 2025, filed 21 Jul 2025.